Suppr超能文献

乳腺钼靶微钙化与乳腺癌肿瘤发生:一项放射病理学分析。

Mammographic microcalcifications and breast cancer tumorigenesis: a radiologic-pathologic analysis.

作者信息

Naseem Madiha, Murray Joshua, Hilton John F, Karamchandani Jason, Muradali Derek, Faragalla Hala, Polenz Chanele, Han Dolly, Bell David C, Brezden-Masley Christine

机构信息

Department of Hematology/Oncology, St. Michael's Hospital, 30 Bond Street, Toronto, Ontario, M5B 1W8, Canada.

Faculty of Medicine, University of Toronto, 1 Kings College Circle, Toronto, ON, M5S 1A8, Canada.

出版信息

BMC Cancer. 2015 Apr 22;15:307. doi: 10.1186/s12885-015-1312-z.

Abstract

BACKGROUND

Microcalcifications (MCs) are tiny deposits of calcium in breast soft tissue. Approximately 30% of early invasive breast cancers have fine, granular MCs detectable on mammography; however, their significance in breast tumorigenesis is controversial. This study had two objectives: (1) to find associations between mammographic MCs and tumor pathology, and (2) to compare the diagnostic value of mammograms and breast biopsies in identifying malignant MCs.

METHODS

A retrospective chart review was performed for 937 women treated for breast cancer during 2000-2012 at St. Michael's Hospital. Demographic information (age and menopausal status), tumor pathology (size, histology, grade, nodal status and lymphovascular invasion), hormonal status (ER and PR), HER-2 over-expression and presence of MCs were collected. Chi-square tests were performed for categorical variables and t-tests were performed for continuous variables. All p-values less than 0.05 were considered statistically significant.

RESULTS

A total of 937 patient charts were included. About 38.3% of the patients presented with mammographic MCs on routine mammographic screening. Patients were more likely to have MCs if they were HER-2 positive (52.9%; p < 0.001). There was a significant association between MCs and peri-menopausal status with a mean age of 50 (64%; p = 0.012). Patients with invasive ductal carcinomas (40.9%; p = 0.001) were more likely to present with MCs than were patients with other tumor histologies. Patients with a heterogeneous breast density (p = 0.031) and multifocal breast disease (p = 0.044) were more likely to have MCs on mammograms. There was a positive correlation between MCs and tumor grade (p = 0.057), with grade III tumors presenting with the most MCs (41.3%). A total of 52.2% of MCs were missed on mammograms which were visible on pathology (p < 0.001).

CONCLUSION

This is the largest study suggesting the appearance of MCs on mammograms is strongly associated with HER-2 over-expression, invasive ductal carcinomas, peri-menopausal status, heterogeneous breast density and multifocal disease.

摘要

背景

微钙化是乳腺软组织中微小的钙沉积物。约30%的早期浸润性乳腺癌在乳腺钼靶检查中可检测到细小、颗粒状的微钙化;然而,它们在乳腺肿瘤发生中的意义存在争议。本研究有两个目的:(1)寻找乳腺钼靶微钙化与肿瘤病理学之间的关联,(2)比较乳腺钼靶和乳腺活检在识别恶性微钙化方面的诊断价值。

方法

对2000年至2012年期间在圣迈克尔医院接受乳腺癌治疗的937名女性进行回顾性病历审查。收集人口统计学信息(年龄和绝经状态)、肿瘤病理学(大小、组织学、分级、淋巴结状态和淋巴管侵犯)、激素状态(雌激素受体和孕激素受体)、人表皮生长因子受体2(HER-2)过表达情况以及微钙化的存在情况。对分类变量进行卡方检验,对连续变量进行t检验。所有p值小于0.05被认为具有统计学意义。

结果

共纳入937份患者病历。在常规乳腺钼靶筛查中,约38.3%的患者出现乳腺钼靶微钙化。HER-2阳性的患者更有可能出现微钙化(52.9%;p < 0.001)。微钙化与围绝经期状态之间存在显著关联,平均年龄为50岁(64%;p = 0.012)。浸润性导管癌患者(40.9%;p = 0.001)比其他肿瘤组织学类型的患者更有可能出现微钙化。乳腺密度不均匀(p = 0.031)和多灶性乳腺疾病(p = 0.044)的患者在乳腺钼靶上更有可能出现微钙化。微钙化与肿瘤分级之间存在正相关(p = 0.057),III级肿瘤出现微钙化的比例最高(41.3%)。在病理检查中可见的微钙化,乳腺钼靶检查漏诊了52.2%(p < 0.001)。

结论

这是规模最大的一项研究,表明乳腺钼靶上微钙化的出现与HER-2过表达、浸润性导管癌、围绝经期状态、乳腺密度不均匀和多灶性疾病密切相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ce3/4407616/be1c05c10a69/12885_2015_1312_Fig1_HTML.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验